ahlam1399
09-30-2016, 05:05 PM
BRIEF-Enanta Pharmaceuticals an**unces AbbVie?s investigational HCV regimen receives U.S. FDA breakthrough therapy designation
* Enanta Pharmaceuticals an**unces AbbVie's investigationalHCV regimen receives U.S. FDA breakthrough therapy designationhttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=InBdAeNWoJQ:NuBG6L7iVAw:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=InBdAeNWoJQ:NuBG6L7iVAw:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=InBdAeNWoJQ:NuBG6L7iVAw:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=InBdAeNWoJQ:NuBG6L7iVAw:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=InBdAeNWoJQ:NuBG6L7iVAw:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/InBdAeNWoJQ
* Enanta Pharmaceuticals an**unces AbbVie's investigationalHCV regimen receives U.S. FDA breakthrough therapy designationhttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=InBdAeNWoJQ:NuBG6L7iVAw:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=InBdAeNWoJQ:NuBG6L7iVAw:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=InBdAeNWoJQ:NuBG6L7iVAw:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=InBdAeNWoJQ:NuBG6L7iVAw:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=InBdAeNWoJQ:NuBG6L7iVAw:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/InBdAeNWoJQ